GE HealthCare Technologies Inc.
GEHC Nasdaq
SEC CIK 1932393
Follow GE HealthCare Technologies
Weekly email: filings, results
Revenue, last quarter
$5.5B
+7.2% vs same quarter last year
Net income
$615M
+37.9% vs same quarter last year
EPS, diluted
$1.36
+38.8% vs same quarter last year
Operating cash flow
$907M
+53% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $20.6B | $2.1B |
| FY24 | $19.7B | $2B |
| FY23 | $19.6B | $1.6B |
| FY22 | $18.3B | $1.9B |
| FY21 | $17.6B | $2.2B |
| FY20 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 40% | 13.4% | 10.1% |
| FY24 | 41.7% | 13.3% | 10.1% |
| FY23 | 40.5% | 12.5% | 8% |
| FY22 | 39.1% | 13.8% | 10.4% |
| FY21 | 40.8% | 15.9% | 12.8% |
| FY20 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $1.5B |
| FY24 | $1.6B |
| FY23 | $1.7B |
| FY22 | $1.8B |
| FY21 | $1.4B |
| FY20 | - |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY25 | $64M | $200M |
| FY24 | $55M | $0 |
| FY23 | $41M | $0 |
| FY22 | $0 | - |
| FY21 | $0 | - |
| FY20 | - | - |
- GE HealthCare Technologies
- Healthcare median
Show the numbers
| Year | GE HealthCare Technologies | Healthcare median |
|---|---|---|
| FY25 | 10.1% | −30.6% |
| FY24 | 10.1% | −47% |
| FY23 | 8% | −58% |
| FY22 | 10.4% | −80.4% |
| FY21 | 12.8% | −71.9% |
| FY20 | - | −62.2% |